WILYY (Demant AS) EV-to-EBITDA : 13.88 (As of Apr. 25, 2025)

View and export this data going back to 2008. Start your Free Trial

What is Demant AS EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Demant AS's enterprise value is $8,633 Mil. Demant AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $622 Mil. Therefore, Demant AS's EV-to-EBITDA for today is 13.88.

The historical rank and industry rank for Demant AS's EV-to-EBITDA or its related term are showing as below:

WILYY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.64 Med: 18.48 Max: 39.98
Current: 14.26

During the past 13 years, the highest EV-to-EBITDA of Demant AS was 39.98. The lowest was 10.64. And the median was 18.48.

WILYY's EV-to-EBITDA is ranked better than
52.04% of 490 companies
in the Medical Devices & Instruments industry
Industry Median: 15.115 vs WILYY: 14.26

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-04-25), Demant AS's stock price is $15.0266. Demant AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $0.782. Therefore, Demant AS's PE Ratio (TTM) for today is 19.22.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Demant AS EV-to-EBITDA Historical Data

The historical data trend for Demant AS's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS EV-to-EBITDA Chart

Demant AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-EBITDA

Get a 7-Day Free Trial

26.31

18.83

13.26

14.13

12.22

Demant AS Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-EBITDA	Get a 7-Day Free Trial															13.26	-	14.13	-	12.22

Competitive Comparison of Demant AS's EV-to-EBITDA

For the Medical Devices subindustry, Demant AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Demant AS's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Demant AS's EV-to-EBITDA falls into.

Save Embed

;

Save Embed

;

Demant AS EV-to-EBITDA Calculation

Demant AS's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	8632.962	/	621.872
	=	13.88

Demant AS's current Enterprise Value is $8,633 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Demant AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $622 Mil.

Demant AS (OTCPK:WILYY) EV-to-EBITDA Explanation

Demant AS's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	15.0266	/	0.782
	=	19.22

Demant AS's share price for today is $15.0266.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Demant AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $0.782.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Demant AS EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Demant AS's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Demant AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OTCPK:WILYY) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

WILLF:USA DEMANc:UK 0RGT:UK DEMANT:Denmark WDH1:Germany DEMA:Austria

Address

Kongebakken 9, Smorum, DNK, 2765

Website

https://www.demant.com

Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.